References
Al-Tawfiq, J. A., Al-Homoud, A. H. and Memish, Z. A. (2020) Remdesivir as a possible therapeutic option for the COVID-19. Travel medicine and infectious disease , 101615-101615.
Ali, S., Mustafa, S., Metzger, W. J. A. and actions (1992) Adenosine-induced bronchoconstriction in an allergic rabbit model: antagonism by theophylline aerosol. 37 (3-4), 165-167.
Almario, B., Wu, S., Peng, J., Alapati, D., Chen, S. and Sosenko, I. R. (2012) Pentoxifylline and prevention of hyperoxia-induced lung injury in neonatal rats.Pediatric research 71 (5), 583-589.
Amvros’ eva, T., Votiakov, V., Andreeva, O., Vladyko, G., Nikolaeva, S., Orlova, S., Azarova, I. and Zgirovskaia, A. (1993) New properties of trental as an inhibitor of viral activity with a wide range of activity. Voprosy virusologii38 (5), 230-233.
Batista, M. N., Carneiro, B. M., Braga, A. C. S. and Rahal, P. J. A. o. v. (2015) Caffeine inhibits hepatitis C virus replication in vitro. 160 (2), 399-407.
Batterman, R., Grossman, A., Dubinsky, J., Mouratoff, G. J. I. r. o. m. and clinics, g. p. (1959) Reevaluation of the usefulness of theobromine calcium gluconate for the management of congestive heart failure and anginal syndrome. 172 (6), 318.
Bauer, T. T., Ewig, S., Rodloff, A. C. and Müller, E. E. (2006) Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clinical Infectious Diseases 43 (6), 748-756.
Becker, A. B., Simons, K. J., Gillespie, C. A. and Simons, F. E. R. (1984) The Bronchodilator Effects and Pharmacokinetics of Caffeine in Asthma. 310 (12), 743-746.
Bishop, N. C., Fitzgerald, C., Porter, P. J., Scanlon, G. A. and Smith, A. C. J. E. j. o. a. p. (2005) Effect of caffeine ingestion on lymphocyte counts and subset activation in vivo following strenuous cycling. 93 (5-6), 606-613.
Bøhn, S. K., Ward, N. C., Hodgson, J. M. and Croft, K. D. (2012) Effects of tea and coffee on cardiovascular disease risk. Food & Function 3 (6), 575-591.
Bruce, M., Scott, N., Shine, P. and Lader, M. J. A. o. G. P. (1992) Anxiogenic effects of caffeine in patients with anxiety disorders. 49 (11), 867-869.
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., Yuan, Y., Chen, H., Li, H., Huang, H., Tu, S., Gong, F., Liu, Y., Wei, Y., Dong, C., Zhou, F., Gu, X., Xu, J., Liu, Z., Zhang, Y., Li, H., Shang, L., Wang, K., Li, K., Zhou, X., Dong, X., Qu, Z., Lu, S., Hu, X., Ruan, S., Luo, S., Wu, J., Peng, L., Cheng, F., Pan, L., Zou, J., Jia, C., Wang, J., Liu, X., Wang, S., Wu, X., Ge, Q., He, J., Zhan, H., Qiu, F., Guo, L., Huang, C., Jaki, T., Hayden, F. G., Horby, P. W., Zhang, D. and Wang, C. (2020a) A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19.
Cao, Y. C., Deng, Q. X. and Dai, S. X. (2020b) Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Med Infect Dis , 101647.
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., Tsoi, H.-W., Lo, S. K.-F., Chan, K.-H., Poon, V. K.-M., Chan, W.-M., Ip, J. D., Cai, J.-P., Cheng, V. C.-C., Chen, H., Hui, C. K.-M. and Yuen, K.-Y. (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet 395 (10223), 514-523.
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., Perlman, S. J. C. h. and microbe (2016) Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. 19 (2), 181-193.
Chavez-Valdez, R., Wills-Karp, M., Ahlawat, R., Cristofalo, E. A., Nathan, A. and Gauda, E. B. J. P. r. (2009) Caffeine modulates TNF-α production by cord blood monocytes: the role of adenosine receptors. 65 (2), 203.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y. and Wei, Y. J. T. L. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. 395 (10223), 507-513.
Cheng, V. C., Lau, S. K., Woo, P. C. and Yuen, K. Y. J. C. m. r. (2007) Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. 20 (4), 660-694.
Childs, E. and de Wit, H. (2008) Enhanced mood and psychomotor performance by a caffeine-containing energy capsule in fatigued individuals. Experimental and Clinical Psychopharmacology 16 (1), 13.
Clark, R. H., Bloom, B. T., Spitzer, A. R. and Gerstmann, D. R. (2006) Reported medication use in the neonatal intensive care unit: data from a large national data set.Pediatrics 117 (6), 1979-87.
Clerici, M., Piconi, S., Balotta, C., Trabattoni, D., Capetti, A., Fusi, M. L., Ruzzante, S., Longhi, R., Colombo, M. C. and Moroni, M. (1997) Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons. Journal of Infectious Diseases 175 (5), 1210-1215.
Coccheri, S. and Bignamini, A. A. (2016) Pharmacological adjuncts for chronic venous ulcer healing . SAGE Publications Sage UK: London, England.
Cohen, J. and Normile, D. (2020)New SARS-like virus in China triggers alarm . American Association for the Advancement of Science.
Conti, P., Ronconi, G., Caraffa, A., Gallenga, C., Ross, R., Frydas, I., Kritas, S. J. J. o. b. r. and agents, h. (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. 34 (2).
Corbel, M., Boichot, E. and Lagente, V. (2000) Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Brazilian Journal of Medical and Biological Research 33 (7), 749-754.
Dahl, J., You, J. and Benjamin, T. L. J. J. o. v. (2005) Induction and utilization of an ATM signaling pathway by polyomavirus. 79 (20), 13007-13017.
Daniel, R., Marusich, E., Argyris, E., Zhao, R. Y., Skalka, A. M. and Pomerantz, R. J. J. J. o. v. (2005) Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells. 79 (4), 2058-2065.
Dekker, J., Hooper, S. B., van Vonderen, J. J., Witlox, R. S., Lopriore, E. and Te Pas, A. B. J. P. r. (2017) Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial. 82 (2), 290-296.
Deree, J., Martins, J., De Campos, T., Putnam, J. G., Loomis, W. H., Wolf, P. and Coimbra, R. (2007) Pentoxifylline attenuates lung injury and modulates transcription factor activity in hemorrhagic shock. Journal of Surgical Research 143 (1), 99-108.
Dettelbach, H. R. and Aviado, D. M. (1985) Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. The Journal of Clinical Pharmacology 25 (1), 8-26.
Dobson, N. R., Patel, R. M., Smith, P. B., Kuehn, D. R., Clark, J., Vyas-Read, S., Herring, A., Laughon, M. M., Carlton, D. and Hunt, C. E. J. T. J. o. p. (2014) Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. 164 (5), 992-998. e3.
Doyen, D., Moceri, P., Ducreux, D. and Dellamonica, J. (2020) Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet .
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., Peng, C., Yuan, M., Huang, J., Wang, Z., Yu, J., Gao, X., Wang, D., Yu, X., Li, L., Zhang, J., Wu, X., Li, B., Xu, Y., Chen, W., Peng, Y., Hu, Y., Lin, L., Liu, X., Huang, S., Zhou, Z., Zhang, L., Wang, Y., Zhang, Z., Deng, K., Xia, Z., Gong, Q., Zhang, W., Zheng, X., Liu, Y., Yang, H., Zhou, D., Yu, D., Hou, J., Shi, Z., Chen, S., Chen, Z., Zhang, X. and Yang, X. (2020) Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences 117 (17), 9490.
Fazely, F., Dezube, B., Allen-Ryan, J., Pardee, A. and Ruprecht, R. (1991) Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells [see comments].
Fernandes, J. L., de Oliveira, R. T. D., Mamoni, R. L., Coelho, O. R., Nicolau, J. C., Blotta, M. H. S. and Serrano Jr, C. V. (2008) Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease—a randomized placebo-controlled study. Atherosclerosis196 (1), 434-442.
Fleming, C. M., He, H., Ciota, A., Perkins, D. and Finn, P. W. (2001) Administration of pentoxifylline during allergen sensitization dissociates pulmonary allergic inflammation from airway hyperresponsiveness. The Journal of Immunology 167 (3), 1703-1711.
Gao, J., Tian, Z. and Yang, X. J. B. t. (2020) Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
Gautret, P., Lagier, J.-C., Parola, P., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E. and Dupont, H. T. J. I. j. o. a. a. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. 105949.
González-Amaro, R., Portales-Pérez, D., Baranda, L., Redondo, J. M., Martínez-Martínez, S., Yáñez-Mó, M., García-Vicuña, R., Cabañas, C. and Sánchez-Madrid, F. (1998) Pentoxifylline inhibits adhesion and activation of human T lymphocytes.The Journal of Immunology 161 (1), 65-72.
González-Espinoza, L., Rojas-Campos, E., Medina-Pérez, M., Peña-Quintero, P., Gómez-Navarro, B. and Cueto-Manzano, A. M. J. N. D. T. (2012) Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial. 27 (5), 2023-2028.
Graham, R. L. and Baric, R. S. (2010) Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. Journal of virology 84 (7), 3134-3146.
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L. and Lescure, F.-X. J. N. E. J. o. M. (2020) Compassionate use of remdesivir for patients with severe COVID-19.
Guo, H., Callaway, J. B. and Ting, J. P. J. N. m. (2015) Inflammasomes: mechanism of action, role in disease, and therapeutics. 21 (7), 677.
Gupta, M., George, A., Sen, R., Rath, S., Durdik, J. M. and Bal, V. (1999) Presence of pentoxifylline during T cell priming increases clonal frequencies in secondary proliferative responses and inhibits apoptosis. The Journal of Immunology 162 (2), 689-695.
Haas, F., Bevelaqua, F., Levin, N., Solazar-Schicchi, J., Reggiani, J. L., Axen, K. and Pineda, H. (1990) Pentoxifylline improves pulmonary gas exchange. Chest 97 (3), 621-627.
Harris, S., Rasyid, A., Nurhayati, E. and Prihartono, J. (2017) Selected benefits of pentoxifylline in acute ischemic stroke management: consideration of risk factors. Health Science International Conference (HSIC 2017). Atlantis Press.
HAYASHI, M., TSUCHIYA, H., YAMAMOTO, N., KARITA, M., SHIRAI, T., NISHIDA, H., TAKEUCHI, A. and TOMITA, K. J. A. r. (2005) Caffeine-potentiated chemotherapy for metastatic carcinoma and lymphoma of bone and soft tissue. 25 (3C), 2399-2405.
Henderson-Smart, D. and Davis, P. J. T. C. L. (2001) Prophylactic methylxanthine for extubation in preterm infants (Cochrane Review). (4).
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H. and Nitsche, A. J. C. (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.
Hong, H., Wang, Y., Chung, H. T. and Chen, C. J. (2020) Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatr Neonatol 61 (2), 131-132.
Horrigan, L. A., Kelly, J. P. and Connor, T. J. J. I. i. (2004) Caffeine suppresses TNF-α production via activation of the cyclic AMP/protein kinase A pathway. 4 (10-11), 1409-1417.
Horrigan, L. A., Kelly, J. P., Connor, T. J. J. P. and therapeutics (2006) Immunomodulatory effects of caffeine: friend or foe? 111 (3), 877-892.
Hsu, C. Y., Norris, J., Hogan, E., Bladin, P., Dinsdale, H., Yatsu, F., Earnest, M., Scheinberg, P., Caplan, L. and Karp, H. (1988) Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebo-controlled double-blind trial.Stroke 19 (6), 716-722.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J. and Gu, X. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395 (10223), 497-506.
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. C. and Wang, H. J. C. (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. 133 (2), 235-249.
Jaruvongvanich, V., Sanguankeo, A., Klomjit, N., Upala, S. J. C., hepatology, r. i. and gastroenterology (2017) Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis. 41 (1), 46-55.
Jobe, A. H. (2017) Caffeine: A Lung Drug for All Very Low Birth Weight Preterm Infants? , American Thoracic Society.
Joob, B. and Wiwanitkit, V. (2020) COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol 82 (5), e177.
Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S. and Katze, M. G. J. M. (2013) Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. 4 (3), e00165-13.
Jung, S., Kim, M. H., Park, J. H., Jeong, Y. and Ko, K. S. J. J. o. m. f. (2017) Cellular antioxidant and anti-inflammatory effects of coffee extracts with different roasting levels. 20 (6), 626-635.
Kelley, J. (1990) Cytokines of the lung. Am Rev Respir Dis 141 (3), 765-788.
Kimura, H., Tsuchiya, H., Shirai, T., Nishida, H., Hayashi, K., Takeuchi, A., Ohnari, I. and Tomita, K. J. J. o. O. S. (2009) Caffeine-potentiated chemotherapy for metastatic osteosarcoma. 14 (5), 556-565.
Klok, F., Kruip, M., van der Meer, N., Arbous, M., Gommers, D., Kant, K., Kaptein, F., van Paassen, J., Stals, M. and Huisman, M. (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research .
Köroğlu, Ö. A., MacFarlane, P. M., Balan, K. V., Zenebe, W. J., Jafri, A., Martin, R. J. and Kc, P. J. N. (2014) Anti-inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide-induced amnionitis. 106 (3), 235-240.
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J. and Hsueh, P.-R. (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents 55 (3), 105924.
Lam, A. and Newhouse, M. T. J. C. (1990) Management of asthma and chronic airflow limitation: are methylxanthines obsolete? 98 (1), 44-52.
Lamkanfi, M., Dixit, V. M. J. A. r. o. c. and biology, d. (2012) Inflammasomes and their roles in health and disease. 28, 137-161.
Lara, D. R. J. J. o. A. s. d. (2010) Caffeine, mental health, and psychiatric disorders. 20 (s1), S239-S248.
Li, H., Tan, G., Tong, L., Han, P., Zhang, F., Liu, B. and Sun, X. (2016) Pentoxifylline inhibits pulmonary inflammation induced by infrarenal aorticcross-clamping dependent of adenosine receptor A2A. American journal of translational research 8 (5), 2210.
Li, J., Li, G., Hu, J.-L., Fu, X.-H., Zeng, Y.-J., Zhou, Y.-G., Xiong, G., Yang, N., Dai, S.-S. and He, F.-T. J. E. j. o. p. (2011) Chronic or high dose acute caffeine treatment protects mice against oleic acid-induced acute lung injury via an adenosine A2A receptor-independent mechanism. 654 (3), 295-303.
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K. and Greenough, T. C. J. N. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. 426 (6965), 450-454.
Lilly, C. M., Sandhu, J. S., Ishizaka, A., Harada, H., Yonemaru, M., Larrick, J. W., Shi, T.-X., O’HANLEY, P. T. and Raffin, T. A. (1989) Pentoxifylline Prevents Tumor Necrosis Factor-induced Lung Injury1-3. Am Rev Respir Dis 139, 1361-1368.
Lipton, R. B., Diener, H. C., Robbins, M. S., Garas, S. Y. and Patel, K. (2017) Caffeine in the management of patients with headache. J Headache Pain 18 (1), 107.
Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J. and Feng, C. J. S. C. L. S. (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. 63 (3), 364-374.
Magnusson, M., Höglund, P., Johansson, K., Jönsson, C., Killander, F., Malmström, P., Weddig, A. and Kjellén, E. (2009) Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).European Journal of Cancer 45 (14), 2488-2495.
Maia, L. and De Mendonça, A. J. E. J. o. N. (2002) Does caffeine intake protect from Alzheimer’s disease? 9 (4), 377-382.
Manzini, S., Perretti, F., Abelli, L., Evangelista, S., Seeds, E. A. and Page, C. P. J. E. j. o. p. (1993) Isbufylline, a new xanthine derivative, inhibits airway hyperresponsiveness and airway inflammation in guinea pigs. 249 (3), 251-257.
Martín, J. F. B., Jiménez, J. L. and MuEóz-Fernández, A. (2003) Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered. Medical Science Monitor9 (6), SR29-SR34.
Matthay, M. A., Aldrich, J. M. and Gotts, J. E. J. T. L. R. M. (2020) Treatment for severe acute respiratory distress syndrome from COVID-19.
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S. and Manson, J. J. (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet .
Mensah-Brown, E., Grujicic, S. S., Maksimovic, D., Jasima, A., Shahin, A. and Lukic, M. (2002) Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Molecular immunology38 (12-13), 941-946.
Misirlioglu, C. H., Demirkasimoglu, T., Kucukplakci, B., Sanri, E. and Altundag, K. (2007) Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer. Medical oncology 24 (3), 308-311.
Montravers, P., Fagon, J.-Y., Gilbert, C., Blanchet, F., Novara, A. and Chastre, J. (1993) Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome. Chest 103 (4), 1017-1022.
Moschino, L., Zivanovic, S., Hartley, C., Trevisanuto, D., Baraldi, E. and Roehr, C. C. J. E. O. R. (2020) Caffeine in preterm infants: where are we in 2020? 6 (1).
Murayama, M., Tsujimoto, K., Uozaki, M., Katsuyama, Y., Yamasaki, H., Utsunomiya, H. and Koyama, A. H. J. M. m. r. (2008) Effect of caffeine on the multiplication of DNA and RNA viruses. 1 (2), 251-255.
Murthy, S., Gomersall, C. D. and Fowler, R. A. (2020) Care for Critically Ill Patients With COVID-19.JAMA .
Okuno, T., Sugiyama, T., Tominaga, M., Kojima, S. and Ikeda, T. (2002) Effects of Caffeine on Microcirculation of the Human Ocular Fundus. Japanese Journal of Ophthalmology 46 (2), 170-176.
Olson, N. and Consigli, R. J. A. j. o. v. r. (1979) Production of labile Newcastle disease virus progeny after infection of chicken embryo cells in the presence of caffeine. 40 (3), 387-392.
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T. and Hu, J. J. N. C. (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. 11 (1), 1-12.
Pal, R., Chaudhary, M. J., Tiwari, P. C., Nath, R., Babu, S. and Pant, K. K. (2016) Pharmacological studies on the anti-inflammatory and immunomodulatory role of pentoxifylline and its interaction with nitric oxide (NO) in experimental arthritis in rats. Inflammopharmacology 24 (5), 221-231.
Pauwels, R. J. C. (1987) The effects of theophylline on airway inflammation. 92 (1), 32S-37S.
Poulakis, N., Androutsos, G., Kazi, D., Bastas, A., Provata, A., Bitsakou, C., Kontozoglou, T., Polyzogopoulou, C. and Tassiopoulou, A. (1999) The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications. Respiratory medicine 93 (1), 52-57.
Poyiadji, N., Shahin, G., Noujaim, D., Stone, M., Patel, S. and Griffith, B. (2020) COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features.Radiology , 201187.
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K. and Wang, W. J. C. I. D. (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China.
Recalcati, S. (2020) Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology n/a (n/a).
Rogers, M. C. and Williams, J. V. (2018) Quis Custodiet Ipsos Custodes? Regulation of Cell-Mediated Immune Responses Following Viral Lung Infections. Annual review of virology 5, 363-383.
Ruan, Q., Yang, K., Wang, W., Jiang, L. and Song, J. (2020a) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.Intensive care medicine , 1-3.
Ruan, Q., Yang, K., Wang, W., Jiang, L. and Song, J. J. I. c. m. (2020b) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. 1-3.
Samieirad, S., Afrasiabi, H., Tohidi, E., Qolizade, M., Shaban, B., Hashemipour, M. A. and Shirvan, I. D. J. J. o. C.-M. S. (2017) Evaluation of caffeine versus codeine for pain and swelling management after implant surgeries: A triple blind clinical trial. 45 (10), 1614-1621.
Sarma, J. V. and Ward, P. A. J. C. P. (2011) Oxidants and redox signaling in acute lung injury. 1 (3), 1365-1381.
Sayed, R., El Wakeel, L., Saad, A. S., Kelany, M. and El-Hamamsy, M. (2020) Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.Medical Oncology 37 (1), 8.
Sebastian, L., Desai, A., Madhusudana, S. N. and Ravi, V. (2009) Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin. International journal of antimicrobial agents 33 (2), 168-173.
Sharp, C., Millar, A. B. and Medford, A. R. (2015) Advances in understanding of the pathogenesis of acute respiratory distress syndrome. Respiration 89 (5), 420-434.
Shaw, S. M., Shah, M. K., Williams, S. G. and Fildes, J. E. J. E. j. o. h. f. (2009) Immunological mechanisms of pentoxifylline in chronic heart failure. 11 (2), 113-118.
Shen, C., Zhang, Z., Xie, T., Ji, J., Xu, J., Lin, L., Yan, J., Kang, A., Dai, Q. and Dong, Y. J. F. i. p. (2020) Rhein Suppresses Lung Inflammatory Injury Induced by Human Respiratory Syncytial Virus Through Inhibiting NLRP3 Inflammasome Activation via NF-κB Pathway in Mice. 10, 1600.
Shiraki, K. and Rapp, F. J. I. (1988) Effects of caffeine on herpes simplex virus. 29 (4), 235-240.
Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S. and Gallagher, T. J. J. o. v. (2011) A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. 85 (2), 873-882.
Sibille, Y. and Reynolds, H. Y. (1990) Macrophages and Polymorphonuclear neutrophils in lung defense and Injury1-2. Am Rev Respir Dis 141, 471-501.
Smits, S. L., de Lang, A., van den Brand, J. M., Leijten, L. M., van IJcken, W. F., Eijkemans, M. J., van Amerongen, G., Kuiken, T., Andeweg, A. C. and Osterhaus, A. D. J. P. p. (2010) Exacerbated innate host response to SARS-CoV in aged non-human primates. 6 (2).
Sugiyama, K., Noda, Y., He, P. J. B., biotechnology, and biochemistry (2001) Suppressive effect of caffeine on hepatitis and apoptosis induced by tumor necrosis factor-α, but not by the anti-Fas antibody, in mice. 65 (3), 674-677.
Sullivan, G. W., Luong, L. S., Carper, H. T., Barnes, R. C. and Mandell, G. L. J. I. (1995) Methylxanthines with adenosine alter TNFα-primed PMN activation. 31 (1), 19-29.
Sullivan, P., Jaffar, Z., Page, C., Costello, J., Bekir, S. and Jeffery, P. J. T. L. (1994) Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. 343 (8904), 1006-1008.
Sunil, V. R., Vayas, K. N., Cervelli, J. A., Malaviya, R., Hall, L., Massa, C. B., Gow, A. J., Laskin, J. D. and Laskin, D. L. (2014) Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation. Experimental and molecular pathology 97 (1), 89-98.
Suresh, R., Vig, M., Bhatia, S., Goodspeed, E. P., John, B., Kandpal, U., Srivastava, S., George, A., Sen, R. and Bal, V. (2002) Pentoxifylline functions as an adjuvant in vivo to enhance T cell immune responses by inhibiting activation-induced death. The Journal of Immunology 169 (8), 4262-4272.
Talik, P., Krzek, J., Ekiert, R. J. S. and Reviews, P. (2012) Analytical techniques used for determination of methylxanthines and their analogues—Recent advances. 41 (1), 1-61.
Tate, M. D., Ong, J. D., Dowling, J. K., McAuley, J. L., Robertson, A. B., Latz, E., Drummond, G. R., Cooper, M. A., Hertzog, P. J. and Mansell, A. J. S. r. (2016) Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition. 6, 27912.
Thébaud, B. and Abman, S. H. (2007) Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. American journal of respiratory and critical care medicine 175 (10), 978-985.
Tilley, S. L. (2011) Methylxanthines in Asthma. Methylxanthines. Berlin, Heidelberg: Springer Berlin Heidelberg. 439-456.
Tobinick, E. J. C. m. r. and opinion (2004) TNF-[alpha] inhibition for potential therapeutic modulation of SARS coronavirus infection. 20 (1), 39.
Tofovic, S. P., Zacharia, L., Carcillo, J. A. and Jackson, E. K. J. S. (2001) Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats. 16 (3), 196-202.
Tong, Z., Dai, H., Chen, B., Abdoh, Z., Guzman, J. and Costabel, U. (2003) Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone. Chest 124 (4), 1526-1532.
Torii, K., Iida, K.-i., Miyazaki, Y., Saga, S., Kondoh, Y., Taniguchi, H., Taki, F., Takagi, K., Matsuyama, M. and Suzuki, R. (1997) Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. American journal of respiratory and critical care medicine 155 (1), 43-46.
Tynell, J., Westenius, V., Rönkkö, E., Munster, V. J., Melén, K., Österlund, P. and Julkunen, I. (2016) Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. The Journal of general virology97 (Pt 2), 344.
van Koert, R. R., Bauer, P. R., Schuitema, I., Sander, J. W. and Visser, G. H. (2018) Caffeine and seizures: A systematic review and quantitative analysis. Epilepsy Behav 80, 37-47.
Wallis, R., Nsubuga, P., Whalen, C., Mugerwa, R., Okwera, A., Oette, D., Jackson, J., Johnson, J. and Ellner, J. (1996) Pentoxifylline Therapy in Human Immunodeficiency Virus—Seropositive Persons with Tuberculosis: A Randomized, Controlled Trial. Journal of Infectious Diseases 174 (4), 727-733.
Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., Zhou, J. and Jiang, H. (2020a) Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. Journal of Infection .
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W. and Xiao, G. (2020b) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 30 (3), 269-271.
Welsh, E. J., Bara, A., Barley, E. and Cates, C. J. (2010) Caffeine for asthma. Cochrane Database of Systematic Reviews (1).
Wen, W. X., Lee, S. Y., Siang, R. and Koh, R. Y. J. A. i. t. (2017) Repurposing pentoxifylline for the treatment of fibrosis: an overview. 34 (6), 1245-1269.
Whitfield, K., Rambaldi, A., Wetterslev, J. and Gluud, C. (2009) Pentoxifylline for alcoholic hepatitis. Cochrane database of systematic reviews (4).
Wu, D., Yang, X. O. J. J. o. M., Immunology and Infection (2020a) TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.
Wu, J., Yan, Z., Schwartz, D. E., Yu, J., Malik, A. B. and Hu, G. J. T. J. o. I. (2013) Activation of NLRP3 inflammasome in alveolar macrophages contributes to mechanical stretch-induced lung inflammation and injury. 190 (7), 3590-3599.
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C. and Yang, C. (2020b) Nervous system involvement after infection with COVID-19 and other coronaviruses.Brain, Behavior, and Immunity .
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., Zhang, X., Pan, A. and Wei, H. (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proceedings of the National Academy of Sciences , 202005615.
Yamazaki, Z. and Tagaya, I. J. J. o. G. V. (1980) Antiviral effects of atropine and caffeine. 50 (2), 429-431.
Yang, C.-Y., Chen, C.-S., Yiang, G.-T., Cheng, Y.-L., Yong, S.-B., Wu, M.-Y. and Li, C.-J. (2018) New insights into the immune molecular regulation of the pathogenesis of acute Respiratory Distress Syndrome. International journal of molecular sciences 19 (2), 588.
Yang, R.-Z., Lee, M.-J., Hu, H., Pollin, T. I., Ryan, A. S., Nicklas, B. J., Snitker, S., Horenstein, R. B., Hull, K. and Goldberg, N. H. J. P. m. (2006) Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. 3 (6).
Ye, M., Ren, Y. and Lv, T. (2020) Encephalitis as a clinical manifestation of COVID-19. Brain, Behavior, and Immunity .
Zhao, W., Ma, L., Cai, C. and Gong, X. J. I. j. o. b. s. (2019) Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK/NF-κB and A2aR signaling in LPS-Induced THP-1 macrophages. 15 (8), 1571.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W. and Lu, R. (2020) A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine .
Zito, P. M. and Murgia III, R. D. (2018) Pentoxifylline (Trental) in Venous Insufficiency and Venous Leg Ulcers. Journal of the Dermatology Nurses’ Association 10 (6), 294-296.
Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S. and Yuen, K. Y. (2016) Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov 15 (5), 327-47.